Navigation Links
Carboplatin Drug Is More Effective Than Radiation Therapy For Testicular Cancer

Treatment with chemotherapy drug Carboplatin is more effective and produces less toxic side// effects compared to radiation therapy for the treatment of testicular cancer.

Professor Tim Oliver and colleagues from The London School of Medicine, UK has reported the results of their study in this week’s issue of The Lancet. 1477 patients with stage 1 seminoma from 70 hospitals in 14 countries were recruited in this study to compare the effect of chemotherapy and radiotherapy. Between 1996 and 2001, the researchers randomly assigned 543 patients with stage I seminoma to receive a single course of carboplatin and 904 patients to receive radiation therapy. After a median follow-up of 3years, they found that relapse-free survival was similar between the two groups (95·4% for the carboplatin group vs. 96·6% for radiation therapy). At 5 years they also found that patients receiving carboplatin were less likely to develop tumors in their remaining testicle.

Treatment for stage 1 seminoma—a cancer of the testes—has been surgical removal of the cancerous testicle (hemi-castration) followed by three weeks radiotherapy. However, patients treated in this way and followed up for up to 30 years have shown increased risk of cancer in another organ and heart disease that begins after 15 years. Professor Oliver states: “This large randomized trial finally establishes after 20 years of research and uncertainty that it is safe to risk less treatment in these patients. We found that one dose of carboplatin in the short term is as safe as radiation and is less toxic. Patients assigned to chemotherapy also had fewer seminomas occurring in the remaining testis than those receiving radiotherapy. Though needing longer follow up and larger numbers to be sure, this surprising finding, were it to apply to primary tumors when first diagnosed is the first hint that it may now be safe to embark on studies of testis conservation instead of hemicastration.”


Related information on Testis Medinida:

Undescended Testis: The testis is responsible for sperm production in men. The general body temperature is 36.9o C. But sperm production is best at a temperature 2o less than this level. This is the reason why the testes are located outside the body.

For more information more:

Know about male reproductive system and testis: The male reproductive system of a man consists of a pair of testes, ducts, accessory glands and a penis. The functions of the male reproductive system are: Production of sperms and Transmission of sperms to the female.

For more information more:


Related medicine news :

1. Carboplatin, Lung cancer drug may be useful in treating breast tumor
2. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
3. Inhaled Steroids Safe & Effective for Children with Asthma
4. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
5. Fluoride Found Effective in Osteoporosis
6. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
7. Implantable Contact Lens Found Safe and Effective
8. Effective And Economical Agent For Anthrax
9. Stem Cell Transplants May Be Effective For MS Patients
10. Effective therapy for Huntingtons disease
11. Chemotherapy Effective for Bladder Cancer
Post Your Comments:

(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
(Date:6/24/2016)... FRANCISCO, Calif. , June 24, 2016 /PRNewswire/ ... ), a biopharmaceutical company developing novel therapeutics for ... unmet needs, today announced the closing of its ... of common stock, at the public offering price ... in the offering were offered by GBT. GBT ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
Breaking Medicine Technology: